1999:HKEXMan Wah Holdings Limited Analysis
Data as of 2026-06-21 - not real-time
HK$3.26
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Man Wah Holdings is trading well below its intrinsic estimate, with the current price around HK$3.26 versus a DCF fair value of roughly HK$5.3, implying upside of over 40%. Technical signals show an oversold condition (RSI near 25) and a bearish MACD divergence, while the stock sits just above a key support level at HK$3.24. The valuation multiples are extremely cheap – a trailing PE of about 7 and a price‑to‑book below 1 – positioning the stock as a classic value play. However, revenue has slipped by roughly 2.5% year‑over‑year and free cash flow is negative, which tempers the optimism. The dividend yield remains attractive at over 7%, though the payout ratio of 58% and limited cash generation raise questions about long‑term sustainability. Volatility is elevated at 36% over the past month, but the beta of 0.5 suggests muted market‑wide swings.
Given the strong cash‑flow from operations, low leverage (debt‑to‑equity ~32%) and a solid dividend, the stock offers a compelling entry point for value‑oriented investors, provided they are comfortable with short‑term technical weakness and cyclical exposure in the consumer furnishings sector.
Given the strong cash‑flow from operations, low leverage (debt‑to‑equity ~32%) and a solid dividend, the stock offers a compelling entry point for value‑oriented investors, provided they are comfortable with short‑term technical weakness and cyclical exposure in the consumer furnishings sector.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI indicating oversold conditions
- Price hovering just above support
- High dividend yield attracting income investors
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Substantial upside to DCF fair value
- Attractive valuation multiples (PE ~7, PB <1)
- Stable dividend payout supporting total return
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued relative to fundamentals
- Low beta indicating defensive characteristics
- Potential for cash‑flow conversion to sustain dividends
Key Metrics & Analysis
Financial Health
Revenue Growth-2.50%
Profit Margin11.03%
P/E Ratio6.9
ROE13.20%
ROA7.12%
Debt/Equity31.84
P/B Ratio0.9
Op. Cash FlowHK$2.4B
Free Cash FlowHK$-131724496
Technical Analysis
TrendBearish
RSI25.7
SupportHK$3.24
ResistanceHK$3.89
MA 20HK$3.58
MA 50HK$3.97
MA 200HK$4.50
MACDBearish
VolumeIncreasing
Fear & Greed Index91.46
Valuation
Fair ValueHK$5.32
Target PriceHK$4.74
Upside/Downside45.40%
GradeUndervalued
TypeValue
Dividend Yield7.36%
Risk Assessment
Beta0.51
Volatility36.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.